Company: IMCR
Filing Date: 2025-01-02
Form Type: 8-K
Source: 0001140361-25-000008
Chunk: 3

Company: Immunocore Holdings plc
Filing Date: 2025-01-02
Form: 8-K
Item: Item 7.01
Chunk 3
---
Item 7.01.      Regulation FD Disclosure  

On January 2, 2025, the Company issued a press release announcing the appointment of Mr. Coy as the Company’s Executive Vice President, Chief Financial
Officer and Head of Corporate Development, a copy of which is attached hereto as Exhibit 99.1 and is hereby incorporated by reference.

The information contained in to Item 7.01 of this Current Report on Form 8-K, including
Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be
deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in any such filing.